Outcomes of ISHLT Lung Transplant AMR

A.B. Cochrane,D. Levine,I. Ponor,M. Philogene,M. Jang,I. Tunc,J. Mathew,H. Luikart,P. Shah,K. Khush,C. Marboe,G. Berry,H. Valentine,S. Agbor-Enoh

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 1|浏览79

暂无评分

摘要

DSA+/AMR subjects show increased risk of CLAD than DSA+ patients without AMR. However, all ISHLT AMR categories showed similar clinical and prognostic profiles, suggesting that the ISHLT diagnostic categories may not represent disease severity.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要